@@365143

Despite all the exhortations to stay out of the sun , a million Americans will develop skin cancer this year . The only good news for die-hard sun worshippers is that treatments are improving . The FDA just gave 3M Pharmaceuticals the go-ahead to market Aldara as a therapy for a common type of basal-cell carcinoma ( BCC )  --  the first new topical approved for BCC in 25 years . In trials , cancerous lesions cleared up after three months for more than 80% of patients . <P> A new medication helps , but it 's no reason to throw common sun-sense to the wind . Aldara does not treat superficial BCC tumors larger in diameter than .8 in. ; in those cases , surgery or other treatment will still be required .                     